CASI Pharmaceuticals, Inc.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2023 | 59.2% | -74.0% | -79.6% |
| FY2024 | 39.1% | -138.8% | -137.6% |
| FY2025 | 48.6% | -217.3% | -232.0% |
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2023 | 59.2% | -74.0% | -79.6% |
| FY2024 | 39.1% | -138.8% | -137.6% |
| FY2025 | 48.6% | -217.3% | -232.0% |